Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of topical bimiralisib in an inflammatory and hyperproliferative skin condition
2019-001189-14Phase 2Completed
- Sponsor
- PIQUR Therapeutics AG
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bimiralisib in psoriasis (6 arms), sponsored by PIQUR Therapeutics AG. Primary endpoint: Area Under the Effect Curve (AUEC) of Total Clinical Score from Day 1 to Day 29. Started Jun 2019; status: completed.
02
Drugs
bimiralisib
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2019-001189-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001189-14.